Welcome back. We hope your weekend was restful and invigorating. Now, of course, the routine returns as those meetings and deadlines beckon. For our part, we will break later today to watch one of the short people accept a well-deserved diploma. Excelsior, as they say. Meanwhile, enjoy a cup of stimulation and survey some news of the world. Hope your day is a good one...
Cannabis Drug Goes On Sale In The UK (The Wall Street Journal)
Lilly Trims Public Relations Staff (Indiana Business Journal)
Valeant Pharma And Biovail Agree To Merge (Bloomberg News)
Sigma Pharma Chairman Resigns (Sydney Morning Herald)
NJ Budget Cut Proposals Will Hurt Biotechs (NJSpotlight)
Medco And Celesio Form European Joint Venture (Bloomberg News)
Amylin Lays Off 60 Employees (San Diego Union-Tribune)
Medicis Pharma Overhauls Executive Team (Associated Press)
Ireland Proposes New Reference Pricing (PharmaTimes)
2 Comments
Hail to the grad!
The Lilly move is good. We need fewer spin doctors and more of the real kind.